Sanofi and AstraZeneca drug, Beyfortus, for RSV in babies and children approved
A drug being developed jointly by Sanofi and AstraZeneca for the prevention of respiratory syncytial…
A drug being developed jointly by Sanofi and AstraZeneca for the prevention of respiratory syncytial…
Illumina Inc. has announced a strategic research collaboration with AstraZeneca to accelerate drug target discovery…
A new group of biotech and pharma companies has been assembled by the Amyloidosis Research…
LogicBio Therapeutics, Inc. has entered into a definitive agreement under which Alexion, AstraZeneca Rare Disease…
Beyfortus, which is being developed jointly by Sanofi and AstraZeneca, is a step closer to…
Ionis Pharmaceuticals, Inc. has presented positive results from a planned 35-week interim analysis of the…
AstraZeneca has said today (August 11) that it has completed its purchase of TeneoTwo including…
A medication used to treat non-small cell lung carcinomas (NSCLC) with specific mutations has demonstrated…
After decades of neglect from big pharma, radiopharmaceuticals are generating major oncology deals globally. This…
AstraZeneca announced today (July 5) it has agreed to buy a company working on a…
A fourth start-up but the first of its kind sees some high-profile companies join forces…
Upstream Bio, a U.S. biotech company focused on inflammation, today exited stealth mode with $200M…